All posts in In the Lab

  • BC.ribbon

    Study Highlights New Drug, Molecular Insight into Triple Negative Breast Cancers

    AACR 2014 study showcases a new drug active against triple-negative breast cancer, and through analysis of the drug’s mechanism of action, offers increased understanding of the biology of this very aggressive form of breast cancer.

Gold
Thistle
Zombie
CMOCO_Aisner
Matching advanced ovarian cancer to the best of three drugs has been a shell game. Jennifer Diamond, MD, and colleagues use algorithm to transform a guess into a science.
CU Cancer Center Director, Dan Theodorescu, MD, PhD, shows a specific microRNA that may be necessary for bladder cancer metastasis.
Cancer may depend on signals transmitted through a chain of cellular events. In Ewing's Sarcoma, CU Cancer Center researchers detail new links that offer chances to break this chain.
Snake
CU Cancer Center Director, Dan Theodorescu, MD, PhD, shows a specific microRNA that may be necessary for bladder cancer metastasis.